cetirizine has been researched along with D-fructopyranose in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fraunfelder, FT; Fraunfelder, FW | 1 |
| Abdel Rahim, M; Gameil, NM; Shawky, NM; Shehatou, GS; Suddek, GM | 1 |
2 other study(ies) available for cetirizine and D-fructopyranose
| Article | Year |
|---|---|
Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Cetirizine; Child; Child, Preschool; Diphosphonates; Drug-Related Side Effects and Adverse Reactions; Eye; Eye Diseases; Female; Fructose; Humans; Infant; Male; Middle Aged; Ophthalmic Solutions; Registries; Retinoids; Topiramate; United States; United States Food and Drug Administration; World Health Organization | 2004 |
Levocetirizine ameliorates high fructose diet-induced insulin resistance, vascular dysfunction and hepatic steatosis in rats.
Topics: Animals; Aorta, Thoracic; Body Weight; C-Reactive Protein; Cetirizine; Diet; Eating; Endothelium, Vascular; Fatty Liver; Fructose; Glucose Tolerance Test; Glutathione; Histamine H1 Antagonists, Non-Sedating; Insulin; Insulin Resistance; L-Lactate Dehydrogenase; Lipid Peroxidation; Lipids; Liver; Male; Protective Agents; Rats, Sprague-Dawley; Superoxide Dismutase; Toll-Like Receptor 4; Vasodilation | 2014 |